Changes in Cerebral Oxygenation During the Prone Position in Patients With Acute Respiratory Distress Syndrome (OXYDV)

Hypoxemia may be refractory to protective ventilation during the acute respiratory distress syndrome (ARDS), justifying the use of other therapies that improved oxygenation and decreased mortality, including prone position (PP).

During ARDS, the majority of patients are responders to PP with increased PaO2 due to homogenization of the ventilation-perfusion ratio. Despite changes in intra-thoracic and intra-abdominal pressure, hemodynamic parameters are not changed.

Besides the fact that the PP improves systemic oxygenation is it the same on cerebral oxygenation? No study has investigated the cerebral oxygenation during PP in patients with ARDS. The cerebral oxygenation may be altered due to the position of the patient and high levels of positive end-expiratory pressure. This decrease oxygenation may be responsible for cognitive impairment when patients awake.

NIRS (Near Infrared Spectroscopy) is a noninvasive tool, capable of delivering information on cerebral oxidative metabolism and its hemodynamic status. It can be used routinely for the management of resuscitation in Intensive Care Unit (ICU) patients. This study is to investigate cerebral oxygenation during prone position in the investigators' patients of ICU.

Study Overview

• Status: Completed
• Conditions: ARDS; Prone Positioning
• Intervention / Treatment: Procedure: Prone positioning

Detailed Description

Primary objectiv Is there a correlation between rSO2 and SpO2 during prone position in patients with ARDS?

Inclusion criteria

Patient with moderate and severe ARDS from 12h, defined by:

• Acute onset of respiratory failure
• Parenchymal opacities Bilateral not fully explained by pleural effusion, nodules, masses or atelectasis
• Unexplained cardiac or vascular insufficiency filling respiratory distress
• PaO2 / FiO2 ≤ 200 with FiO2> 60% and PEEP ≥ 5cmH2O
• Need for invasive mechanical ventilation
• Hemoglobin> 8 g / dL
• Ramsay score 6 sedated with midazolam and Sufentanyl and neuromuscular blockade by Atracurium.

Exclusion criteria

• Participation in another study requiring specific management of ARDS;

• Against-indication for prone position:

  • Burns or wounds in the face, chest and abdominal wall
  • Recent thoraco-abdominal surgical incision
  • Spinal instability, pelvic fracture
  • State of uncontrolled shock
  • intracranial hypertension

• Alteration of the NIRS signal:

  • Brain damage: extra-dural hematoma, subdural hematoma, pneumocephalus, ischemic stroke, subarachnoid hemorrhage, intracerebral expansive process
  • Skin lesions at the electrodes
  • Jaundice bilirubin
  • ECMO
  • Pregnant or breastfeeding women
  • Age less than 18 years
  • Opposition patient, a family member, person of trust or the legal representative for participation in the study.

• Study Type: Observational
• Enrollment (Actual): 10

Contacts and Locations

Study Locations

• France
  • Vannes, France, 56 000
    • CHBA

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

ARDS

Description

Inclusion Criteria:

Patient with moderate and severe ARDS from 12h, defined by:

• Acute onset of respiratory failure
• Parenchymal opacities Bilateral not fully explained by pleural effusion, nodules, masses or atelectasis
• Unexplained cardiac or vascular insufficiency filling respiratory distress
• PaO2 / FiO2 ≤ 200 with FiO2> 60% and PEEP ≥ 5cmH2O
• Need for invasive mechanical ventilation
• Hemoglobin> 8 g / dL
• Ramsay score 6 sedated with midazolam and Sufentanyl and neuromuscular blockade by Atracurium.

Exclusion Criteria:

• Participation in another study requiring specific management of ARDS;

• Against-indication for prone position:

  • Burns or wounds in the face, chest and abdominal wall
  • Recent thoraco-abdominal surgical incision
  • Spinal instability, pelvic fracture
  • State of uncontrolled shock
  • intracranial hypertension

• Alteration of the NIRS signal:

  • Brain damage: extra-dural hematoma, subdural hematoma, pneumocephalus, ischemic stroke, subarachnoid hemorrhage, intracerebral expansive process
  • Skin lesions at the electrodes
  • Jaundice bilirubin
  • ECMO
  • Pregnant or breastfeeding women
  • Age less than 18 years
  • Opposition patient, a family member, person of trust or the legal representative for participation in the study.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Brain oxygenation	18 hours

Collaborators and Investigators

• Sponsor: Centre Hospitalier Bretagne Atlantique

Study record dates

Study Major Dates

• Study Start: April 1, 2015
• Primary Completion (Actual): February 1, 2017
• Study Completion (Actual): February 1, 2017

Study Registration Dates

• First Submitted: April 9, 2015
• First Submitted That Met QC Criteria: April 13, 2015
• First Posted (Estimate): April 14, 2015

Study Record Updates

• Last Update Posted (Actual): March 13, 2017
• Last Update Submitted That Met QC Criteria: March 9, 2017
• Last Verified: March 1, 2017

More Information

Terms related to this study

• Keywords: Cerebral oxygenation; Prone positioning; Near infrared spectroscopy; Acute respiratory distress syndrom
• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Respiration Disorders; Lung Diseases; Infant, Newborn, Diseases; Lung Injury; Infant, Premature, Diseases; Respiratory Distress Syndrome; Respiratory Distress Syndrome, Newborn; Acute Lung Injury
• Other Study ID Numbers: 2015-005-YF